ORI
STML
Oak Ridge Investments’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-36,208
| Closed | -$310K | – | 154 |
|
|
2017
Q1 | $310K | Buy |
36,208
+2,055
| +6% | +$17.6K | 0.01% | 139 |
|
|
2016
Q4 | $365K | Buy |
34,153
+21,357
| +167% | +$228K | 0.01% | 137 |
|
|
2016
Q3 | $139K | Buy |
12,796
+2,663
| +26% | +$28.9K | ﹤0.01% | 143 |
|
|
2016
Q2 | $69K | Hold |
10,133
| – | – | ﹤0.01% | 140 |
|
|
2016
Q1 | $47K | Sell |
10,133
-142
| -1% | -$659 | ﹤0.01% | 136 |
|
|
2015
Q4 | $65K | Sell |
10,275
-3,366
| -25% | -$21.3K | ﹤0.01% | 142 |
|
|
2015
Q3 | $120K | Hold |
13,641
| – | – | ﹤0.01% | 142 |
|
|
2015
Q2 | $161K | Hold |
13,641
| – | – | ﹤0.01% | 143 |
|
|
2015
Q1 | $197K | Buy |
13,641
+870
| +7% | +$12.6K | ﹤0.01% | 146 |
|
|
2014
Q4 | $218K | Sell |
12,771
-1,257
| -9% | -$21.5K | 0.01% | 142 |
|
|
2014
Q3 | $175K | Buy |
+14,028
| New | +$175K | ﹤0.01% | 143 |
|